Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization

Annals of Thoracic Surgery

Volumn 66, Issue 2, 1998, Pages 487-492

  Lazar, Harold L ^a   Volpe, Charles ^a   Bao, Yusheng ^a   Rivers, Samuel ^a   Vita, Joseph A ^a   Keaney Jr, John F ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CORONARY VESSELS; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; ENALAPRILAT; HEART ARREST, INDUCED; HEART RATE; INFUSIONS, INTRAVENOUS; MYOCARDIAL REVASCULARIZATION; SWINE; TACHYCARDIA, VENTRICULAR; VASOMOTOR SYSTEM; VENTRICULAR FIBRILLATION;

EID: 0031692296     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00450-0     Document Type: Article

References (23)

1. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 327:1992;669-677.
2. Yusuf S., Pepine C.J., Garces C., et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 340:1992;1173-1178.
3. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
4. Mancini G.B.J., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improved endothelial vasomotor dysfunction in patients with coronary artery disease The TREND (Trial on Reversing Endothelial Dysfunction Study) . Circulation. 94:1996;258-265.
5. Ertl G., Kloner R.A., Alexander R.W., Braunwald E. Limitation of experimental infarct size by angiotensin converting enzyme inhibition. Circulation. 65:1982;40-48.
6. Hartman J.C. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Ann Thorac Surg. 60:1995;789-792.
7. Hock C.E., Ribeiro G.T., Lefer A.M. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. Am Heart J. 109:1985;222-228.
8. Engelman R.M., Rousou J.A., Iyengar J., Das D.K. Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction. Ann Thorac Surg. 52:1991;918-926.
9. Gurevitch J., Peuni D., Frolkis T., et al. Captopril in cardioplegia and reperfusion protective effects on the ischemic heart . Ann Thorac Surg. 63:1997;627-633.
10. Piana R.N., Wang S.Y., Friedman M., Sellke F.W. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation. 93:1996;544-551.
11. Clozel M., Kuhn H., Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 16:1990;532-540.
12. Griendling K., Ollerenshaw J.D., Minieri C.A., Alexander R.W. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148.
13. Lazar H.L., Zhang X., Hamasaki T., et al. Heparin-bonded circuits decrease myocardial ischemic damage an experimental study . Ann Thorac Surg. 63:1997;1701-1705.
14. Marturana P.A., Linz W., Scholkens B.A. Does bradykinin play a role in the cardiac anti-ischemic effect of the ACE inhibitors? Basic Res Cardiol. 86:1991;293-296.
15. Scholkens B.A., Linz W., Marturana P.A. Experimental and cardiovascular benefits of angiotensin converting enzyme inhibitors beyond blood pressure reduction . J Cardiovasc Pharmacol. 18:1991;526-530.
16. Sato H., Zhao Z.-Q., McGee D.S., Williams M.W., Hammon J.W., Vinten-Johansen J. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional post-ischemic injury. J Thorac Cardiovasc Surg. 100:1995;302-314.
17. Hecker M., Bara A.T., Busse R. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors role of endothelium-derived kinins . J Vasc Res. 30:1993;257-262.
18. Bossaller C., Auch-Schwelk W., Grafe M., Graf K., Baumgarten C., Fleck E. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation. Agents Actions. 38:1992;171-177.
19. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 95:1997;588-593.
20. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 97:1996;1916-1923.
21. Johnston C.I., Clappison B.H., Anderson W.P., Yasujima M. Effects of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol. 49:1982;1405-1409.
22. 2 kinin receptors in cultured porcine endothelial cells. J Pharmacol Exp Ther. 252:1990;581-585.
23. Westlin W., Mulane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation. 77:(Suppl):1988;30-39.